ba0001pp1 | Clinical case posters | ECTS2013
Gotherstrom Cecilia
, Blanc Katarina Le
, Astrom Eva
, Taslimi Jahan
, Graham Gail E
, Ewald Uwe
, Westgren Magnus
Background: Treatment with multipotent mesenchymal stromal cells (MSC) has the potential to ameliorate mesodermal disorders.Objective: To treat severe osteogenesis imperfecta (OI) with fetal MSC.Methods: Ten years ago, we treated a fetus with OI type III (COL1A2: c.3008G>A, p.Gly1003Asp) in utero with fetal HLA-mismatched MSC. The procedure was uncomplicated. At the age of 4 months i.v. pamidronete treatment was starte...